Pure Global
NCT05214989

Tailored Interventions to Increase Cardiac Rehabilitation Enrollment

Development of a Tailored Intervention to Increase Veteran Enrollment in Cardiac Rehabilitation (CDA 19-391)
VA Office of Research and Development·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cardiovascular Disease
Drug/Device/Intervention
Tailored intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
VA Office of Research and Development
Location
Nashville, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2024
End date
Dec 31, 2025
Enrollment
25 participants
Primary outcome

Qualitative interviews

Summary

Cardiac rehabilitation, an outpatient program that includes supervised exercise and
 cardiovascular risk factor education, is one of the most important therapies for patients
 with cardiovascular disease. Unfortunately, very few Veterans with cardiovascular disease
 enroll in cardiac rehabilitation programs. This proposal will evaluate Veterans' individual
 barriers to attending cardiac rehabilitation with both surveys and interviews. Using this
 information, the investigators will develop a behavioral intervention to encourage Veterans
 to enroll in outpatient cardiac rehabilitation programs. This intervention will be
 individually tailored to Veterans with the information- motivation-behavioral skills model, a
 theory of behavior change. The investigators will test the tailored intervention with a
 proof-of-concept study in Veterans hospitalized with cardiovascular disease at the Veterans
 Affairs Tennessee Valley Healthcare System. This project is relevant to Veterans' health
 because increasing enrollment in cardiac rehabilitation will decrease mortality and increase
 quality of life in Veterans with cardiovascular disease.

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseHeart disease, unspecifiedAtherosclerotic cardiovascular disease, so describedAtherosclerotic heart disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05214989
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05214989 through Pure Global AI's free database. This phase not specified trial is sponsored by VA Office of Research and Development and is currently Not yet recruiting. The study focuses on Cardiovascular Disease. Target enrollment is 25 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.